Version 1
: Received: 17 August 2021 / Approved: 18 August 2021 / Online: 18 August 2021 (14:15:22 CEST)
How to cite:
Widodo, W.; Denta, A.O.; Sunarti, S.; Haltrich, D. Milk Fermented with Lactobacillus casei Strain AP Improves Lipid Profiles in Obese Indonesian Adults. Preprints2021, 2021080385. https://doi.org/10.20944/preprints202108.0385.v1
Widodo, W.; Denta, A.O.; Sunarti, S.; Haltrich, D. Milk Fermented with Lactobacillus casei Strain AP Improves Lipid Profiles in Obese Indonesian Adults. Preprints 2021, 2021080385. https://doi.org/10.20944/preprints202108.0385.v1
Widodo, W.; Denta, A.O.; Sunarti, S.; Haltrich, D. Milk Fermented with Lactobacillus casei Strain AP Improves Lipid Profiles in Obese Indonesian Adults. Preprints2021, 2021080385. https://doi.org/10.20944/preprints202108.0385.v1
APA Style
Widodo, W., Denta, A.O., Sunarti, S., & Haltrich, D. (2021). Milk Fermented with <em>Lactobacillus casei </em>Strain AP Improves Lipid Profiles in Obese Indonesian Adults. Preprints. https://doi.org/10.20944/preprints202108.0385.v1
Chicago/Turabian Style
Widodo, W., Sunarti Sunarti and Dietmar Haltrich. 2021 "Milk Fermented with <em>Lactobacillus casei </em>Strain AP Improves Lipid Profiles in Obese Indonesian Adults" Preprints. https://doi.org/10.20944/preprints202108.0385.v1
Abstract
Obesity and hyperglycemia can trigger various diseases, including diabetes mellitus and cardiovascular ailments. Health-promoting fermented milk products can be useful in tackling these issues. One such product is the fermented milk developed using Lactobacillus casei AP, a probiotic strain from Indonesia that has not been tested in humans thus far. Our objective was to examine the effects of L. casei AP-fermented milk products on lipid profiles, blood glucose levels and monocyte chemoattractant protein-1 (MCP-1) levels in obese adults. A total of 29 obese subjects were given L. casei AP-fermented milk products, and their fasting blood glucose, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride levels were measured using diagnostic system kits. MCP-1 levels were measured using enzyme-linked immunosorbent assay. It was determined that the administration of L. casei AP-fermented milk products significantly reduced total cholesterol, LDL and triglyceride levels (p < 0.05); however, it did not increase HDL (p > 0.05), MCP-1 or fasting blood glucose levels (p ≥ 0.05). In conclusion, in obese Indonesian adults, L. casei AP-fermented milk might reduce total cholesterol, LDL and triglyceride levels but may not affect HDL, MCP-1 or fasting blood glucose levels.
Keywords
Obesity; Lactobacillus casei AP; probiotic; fermented milk; lipid profiles
Subject
Biology and Life Sciences, Food Science and Technology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
